Following last week’s announcement by Theresa May that 20 British companies are expanding their investment in Kenya and supporting 100,000 new jobs in the process, UK High Commissioner Nic Hailey yesterday visited the AstraZeneca team to discuss how the Anglo–Swedish multinational pharmaceutical and biopharmaceutical company could support the country’s target of achieving universal healthcare.
The President’s ambitious healthcare reforms aim to achieve 100 per cent health coverage for every Kenyan. By the end of 2018, the government hopes it will have increased the number of people accessing healthcare from 16.53 million to 25.74 million, rising to 51.57 million, Kenya’s projected population, by 2022.
AstraZeneca East Africa Region is represented in Ethiopia, Kenya, Rwanda, Tanzania and Uganda.
The year before registering as a legal entity in Kenya in 2016, AstraZeneca established an East African regional distribution hub enabling them to bring their products closer to their patients.
AstraZeneca’s Healthy Heart Africa (HHA) is their global signature programme committed to tackling hypertension and the increasing burden of cardiovascular disease (CVD) across Africa. The innovative programme was launched in Kenya October 2014, in collaboration with the Kenyan Ministry of Health and a group of well-respected implementing partners.